Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
Open accessAbstract
PURPOSE: This study presents the 2016 nationwide cancer statistics in Korea, including cancer incidence, survival, prevalence, and mortality. MATERIALS AND METHODS: Cancer incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database and followed until December 31, 2017. Mortality data from 1983 to 2016 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2017 among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality, and prevalence and 5-year relative survivals were also calculated. RESULTS: Overall, 229,180 and 78,194 Koreans were newly diagnosed and died from cancer in 2016, respectively. The ASRs for cancer incidence and mortality in 2016 were 269.0 and 79.8 per 100,000 individuals, respectively. The all-cancer incidence rate increased significantly by 3.6% annually from 1999 to 2011 and started to decrease after 2011 (2011-2016; annual percent change, -3.1%). However, overall cancer mortality has decreased 2.7% annually since 2002. The 5-year relative survival rate for patients diagnosed with cancer between 2012 and 2016 was 70.6%, an improvement from the 41.2% for patients diagnosed between 1993 and 1995. CONCLUSION: The cancer prevalence in Korea has increased very fast as survival has improved remarkably. The high prevalence of cancer emphasizes the need for comprehensive cancer control efforts in Korea.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
These guideline modifications have likely led to declines in thyroid cancer incidence rates in the Republic of Korea since 2010 as well as in the United States.
“This has likely led to declines in thyroid cancer incidence rates in the Republic of Korea since 2010 as well as in the United States.154,155”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [154]
Selected Findings, §3 (page not provided), reports that thyroid cancer incidence in Korea fell by 12.6% annually starting in 2011. It does not attribute the decline to guideline modifications or report a corresponding trend in the United States. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · see citing works
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
Jung, K., Won, Y., Kong, H., et al. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2018.143 · Cited by 396 · see citing works
Self-citationShin, H., Won, Y., Jung, K., et al. (2005) · Cancer Research and Treatment · doi:10.4143/crt.2005.37.6.325 · Cited by 326 · see citing works
Self-citationPrediction of Cancer Incidence and Mortality in Korea, 2016
Jung, K., Won, Y., Oh, C., et al. (2016) · Cancer Research and Treatment · doi:10.4143/crt.2016.092 · Cited by 70 · see citing works
Self-citationAjiki, W., Tsukuma, H., & Oshima, A. (1998) · PubMed · Cited by 47 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [13]Ederer F Heise H Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10 Bethesda, MD National Cancer Institute 1959
Cited by
Sorted by citations
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · see citing works
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064 · see citing works
Global Burden of 5 Major Types of Gastrointestinal Cancer
Arnold, M., Abnet, C. C., Neale, R. E., Vignat, J., Giovannucci, E. L., McGlynn, K. A., & Bray, F. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.068 · Cited by 2,027 · see citing works
Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics
Song, B., Park, E. Y., Kim, K. J., & Ki, S. H. (2022) · Cancers · doi:10.3390/cancers14194601 · Cited by 55 · see citing works
- Authors
- Jung, K.-W., Won, Y.-J., Kong, H.-J., Lee, E. S., & Registries, T. C. O. P.-B. R. C.
- Affiliations
- National Cancer Center (KR)
- Corresponding author
- Won, Young-Joo
- Venue
- Cancer Research and Treatment
- Publisher
- Korean Cancer Association
- Published
- 2019-04-15
- Volume
- 51
- Issue
- 2
- Pages
- 417-430
- ISSN
- 1598-2998 (ISSN-L)
- 2005-9256
- PMC
- PMC6473271
- OpenAlex
- W2921046410
- Cited by
- 392
- References
- 5
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 14 · 2023: 23 · 2022: 57 · 2021: 102 · 2020: 132 · 2019: 38 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2012: 1
- FWCI
- 34.32
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Cancer Research and Treatment (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Ministry of Health and Welfare (1860390)
- National Cancer Center (1910130)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
- Keywords
- cancer incidence, cancer mortality, cancer prevalence, cancer survival, 5-year relative survival, age-standardized rates, cancer trends, cancer control, Korea
- MeSH terms
- Age Factors, Female, Humans, Male, Neoplasms, Population Surveillance, Registries, Incidence, Prevalence, Survival Rate, Databases, Factual, History, 21st Century, Republic of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
